skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Novel corona virus disease (COVID‐19) in pregnancy: What clinical recommendations to follow?

Acta obstetricia et gynecologica Scandinavica, 2020-04, Vol.99 (4), p.439-442 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG) ;Copyright © 2020 Acta Obstetricia et Gynecologica Scandinavica ;info:eu-repo/semantics/openAccess ;ISSN: 0001-6349 ;ISSN: 1600-0412 ;EISSN: 1600-0412 ;DOI: 10.1111/aogs.13836 ;PMID: 32141062

Full text available

Citations Cited by
  • Title:
    Novel corona virus disease (COVID‐19) in pregnancy: What clinical recommendations to follow?
  • Author: Liang, Huan ; Acharya, Ganesh
  • Subjects: Betacoronavirus ; Coronavirus Infections - diagnosis ; Coronavirus Infections - drug therapy ; Coronavirus Infections - epidemiology ; COVID-19 ; Disease Outbreaks ; Disease Susceptibility ; Female ; Humans ; Medical disciplines: 700 ; Medicin och hälsovetenskap ; Medisinske Fag: 700 ; Patient Care Planning ; Pneumonia, Viral - diagnosis ; Pneumonia, Viral - drug therapy ; Pneumonia, Viral - epidemiology ; Practice Guidelines as Topic ; Pregnancy ; Pregnancy Complications, Infectious - diagnosis ; Pregnancy Complications, Infectious - prevention & control ; Pregnancy Complications, Infectious - virology ; SARS-CoV-2 ; VDP
  • Is Part Of: Acta obstetricia et gynecologica Scandinavica, 2020-04, Vol.99 (4), p.439-442
  • Description: Pregnancy is a state of partial immune suppression which makes pregnant women more vulnerable to viral infections, and the morbidity is higher even with seasonal influenza. Therefore, the COVID‐19 epidemic may have serious consequences for pregnant women. Although the vast majority of cases of COVID‐19 are currently in China, the risk of outward transmission appears to be significantly raising global concern. Human to human transmission of the virus is proven to occur,1, 2 perhaps even from asymptomatic patients,3, 4 and the mortality is substantial, especially among frail, elderly patients with comorbidities.5 Although there have been some criticisms surrounding suppression of early warnings, and slow initial response followed by heavy‐handed quarantine measures, as well as concerns expressed about the capacity to cope with the large number of patients, and shortage of protective equipment and in‐hospital infections leading to deaths among a substantial number of healthcare professionals,6, 7 China's effort to contain the disease and slow down its spread in China and world‐wide has been commendable. A large number of cases requiring hospitalization and intensive care is a serious burden even for affluent countries with well‐developed healthcare systems. However, the Chinese government, its health professionals, and the public, have set a new standard for handling the epidemic, and they have certainly contributed to reducing the potential risk of outbreak in neighboring countries with weaker healthcare systems. Furthermore, Chinese researchers and health professionals have generously shared their data, knowledge, experience and expertise that has helped to develop diagnostic tools, clinical management algorithms, set up clinical trials, and accelerate vaccine development. Clinical course and outcome of a substantial number of COVID‐19 patients have been reported, and recommendations regarding the care of such patients have been issued by several national health authorities across the world. However, the practices seem to vary considerably.
  • Publisher: United States: Wiley Subscription Services, Inc
  • Language: English
  • Identifier: ISSN: 0001-6349
    ISSN: 1600-0412
    EISSN: 1600-0412
    DOI: 10.1111/aogs.13836
    PMID: 32141062
  • Source: Journals@Ovid Open Access Journal Collection Rolling
    MEDLINE
    NORA Norwegian Open Research Archives
    SWEPUB Freely available online

Searching Remote Databases, Please Wait